-
My Account
My Account
-106.15 (-2%) -104.6 (-1.97%) 
12.41 pm | 27 Dec 2018 | Source: PTI
The newly launched product is in the strengths of 0.8 g and 2.4 g packets, and is a therapeutic equivalent generic version of Renvela (sevelamer carbo...
11.41 am | 24 Dec 2018 | Source: PTI
The product is a therapeutic equivalent to generic version of Aggrenox (aspirin and extended-release dipyridamole) capsules, the company said in a BSE...
10.54 am | 30 Nov 2018 | Source: Moneycontrol.com
We recommend traders to buy this stock in the range of Rs 2650 to 2625 with a price target of Rs 2900 and a stop loss placed below Rs 2520, says Adity...
11.19 am | 28 Nov 2018 | Source: PTI
Dr Reddy's Laboratories Ltd launched Chlorthalidone tablets USP in the strengths of 25 mg and 50 mg, a therapeutic equivalent generic version of H...
8.57 am | 21 Nov 2018 | Source: Moneycontrol.com
Dr Reddy's had booked sales of around $10-15 million days after its launch before it was stayed by the court....
2.52 pm | 12 Nov 2018 | Source: PTI
"On November 9, 2018, the Regulatory Authority of Germany (Regierung von Oberbayem) concluded the follow-on audit of our formulations manufacturing fa...
5.14 pm | 09 Nov 2018 | Source: Moneycontrol.com
To beat the pricing pressure and maintain profit margins, large generic drug makers have responded by slashing their generic pipelines and ANDA filing...
2.12 pm | 31 Oct 2018 | Source: Moneycontrol.com
ICICI Direct is bullish on Dr Reddy’s Laboratories has recommended buy rating on the stock with a target price of Rs 2700 in its research report dat...
1.52 pm | 31 Oct 2018 | Source: PTI
The Hyderabad-based company has received the approval from the US Food and Drug Administration (USFDA) to market its product which is a generic equiva...
9.57 pm | 30 Oct 2018 | Source: PTI
As per the USFDA, a Form 483 is issued to a firm's management at the conclusion of an inspection when investigator has observed any conditions tha...
6.35 pm | 30 Oct 2018 | Source: Moneycontrol.com
Moneycontrol reported in August that some drug makers are working towards producing APIs and key starting materials in house, while others have starte...
2.35 pm | 29 Oct 2018 | Source: Moneycontrol.com
The pharma major reported a rise of 77 percent (year-on-year) in its net profit at Rs 503.8 crore. The company had reported a profit of Rs 284.9 crore...
9.17 pm | 26 Oct 2018 | Source: Moneycontrol.com
“Looking ahead, our priority will be to resolve pending regulatory issues, and continue to work on execution and cost structures that will enable af...
3.37 pm | 26 Oct 2018
NULL...
3.17 pm | 26 Oct 2018 | Source: Moneycontrol.com
The revenue rose to Rs 3,797.8 crore against Rs 3,546 crore that the company posted during the corresponding quarter of last year. This implies a rise...
9.12 am | 26 Oct 2018 | Source: Moneycontrol.com
The effect of Suboxone based on US court order is likely to weigh as well....
3.41 pm | 24 Oct 2018 | Source: Moneycontrol.com
A portion of complex abbreviated new drug applications is filed from this facility...
9.51 am | 19 Oct 2018 | Source: Moneycontrol.com
The drug maker's partner Fresenius Kabi has completed clinical trial for Pegfilgrastim and announced that the drug has met primary end point in tw...
5.40 pm | 17 Oct 2018 | Source: Moneycontrol.com
Net Sales are expected to increase by 10.8 percent Y-o-Y (up 5.6 percent Q-o-Q) to Rs. 3,930 crore, according to HDFC Securities....
11.23 am | 17 Oct 2018 | Source: Moneycontrol.com
Net Sales are expected to increase by 5.3 percent Y-o-Y (up 0.4 percent Q-o-Q) to Rs. 3,750 crore, according to Sharekhan....
